These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 9345307)

  • 1. Renal elimination of islet amyloid polypeptide.
    Leckström A; Björklund K; Permert J; Larsson R; Westermark P
    Biochem Biophys Res Commun; 1997 Oct; 239(1):265-8. PubMed ID: 9345307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of islet amyloid polypeptide/amylin-immunoreactivity in urine collected from healthy volunteers after ingestion of a carbohydrate-rich meal.
    van Hulst KL; Nieuwenhuis MG; Höppener JW; Lips CJ; Blankenstein MA
    Exp Clin Endocrinol Diabetes; 1996; 104(2):177-9. PubMed ID: 8740943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated fasting plasma level of islet amyloid polypeptide (IAPP) in chronic alcoholic pancreatitis (CAP).
    Gasiorowska A; Orszulak-Michalak D; Kozlowska A; Malecka-Panas E
    Hepatogastroenterology; 2003; 50(49):258-62. PubMed ID: 12630035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment.
    de Koning EJ; Fleming KA; Gray DW; Clark A
    J Pathol; 1995 Feb; 175(2):253-8. PubMed ID: 7738722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Islet amyloid polypeptide in patients with pancreatic cancer and diabetes.
    Permert J; Larsson J; Westermark GT; Herrington MK; Christmanson L; Pour PM; Westermark P; Adrian TE
    N Engl J Med; 1994 Feb; 330(5):313-8. PubMed ID: 8277951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma glucose, serum insulin and C-peptide in patients with various stages of chronic renal failure].
    Jovanović D; Djukanović Lj; Veljović R; Manojlović D
    Srp Arh Celok Lek; 1994; 122(3-4):59-61. PubMed ID: 17972808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet amyloid polypeptide in Psammomys obesus (sand rat): effects of nutritionally induced diabetes and recovery on low-energy diet or vanadyl sulfate treatment.
    Leckström A; Ziv E; Shafrir E; Westermark P
    Pancreas; 1997 Nov; 15(4):358-66. PubMed ID: 9361089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrapulmonary administration of natural honey solution, hyperosmolar dextrose or hypoosmolar distill water to normal individuals and to patients with type-2 diabetes mellitus or hypertension: their effects on blood glucose level, plasma insulin and C-peptide, blood pressure and peaked expiratory flow rate.
    Al-Waili N
    Eur J Med Res; 2003 Jul; 8(7):295-303. PubMed ID: 12911866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of plasma amylin in advanced renal failure.
    Watschinger B; Hartter E; Traindl O; Pohanka E; Pidlich J; Kovarik J
    Clin Nephrol; 1992 Mar; 37(3):131-4. PubMed ID: 1563116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Falsely elevated plasma aldosterone concentration by direct radioimmunoassay in chronic renal failure.
    Koshida H; Miyamori I; Miyazaki R; Tofuku Y; Takeda R
    J Lab Clin Med; 1989 Sep; 114(3):294-300. PubMed ID: 2769019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Islet amyloid polypeptide, a novel pancreatic peptide, is a circulating hormone secreted under glucose stimulation.
    Nakazato M; Miyazato M; Asai J; Mitsukawa T; Kangawa K; Matsuo H; Matsukura S
    Biochem Biophys Res Commun; 1990 Jun; 169(2):713-8. PubMed ID: 2357227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma islet amyloid polypeptide levels in obesity, impaired glucose tolerance and non-insulin-dependent diabetes mellitus.
    Enoki S; Mitsukawa T; Takemura J; Nakazato M; Aburaya J; Toshimori H; Matsukara S
    Diabetes Res Clin Pract; 1992 Jan; 15(1):97-102. PubMed ID: 1541241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion.
    Ludvik B; Clodi M; Kautzky-Willer A; Schuller M; Graf H; Hartter E; Pacini G; Prager R
    J Clin Invest; 1994 Nov; 94(5):2045-50. PubMed ID: 7962550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet amyloid polypeptide (amylin) does not seem to be directly involved in the development of gestational diabetes mellitus.
    Grigorakis SI; Alevizaki M; Rapti E; Anastasiou E; Alevizaki CC; Souvatzoglou A
    Gynecol Obstet Invest; 1997; 44(1):6-10. PubMed ID: 9251946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control.
    Chisalita SI; Lindström T; Eson Jennersjö P; Paulsson JF; Westermark GT; Olsson AG; Arnqvist HJ
    Acta Diabetol; 2009 Mar; 46(1):35-42. PubMed ID: 18777156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of arginine on the secretion of insulin and islet amyloid polypeptide in humans.
    Larsson H; Ahrén B
    Pancreas; 1995 Aug; 11(2):201-5. PubMed ID: 7479680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet amyloid polypeptide response to glucose, insulin, and somatostatin analogue administration.
    Mitsukawa T; Takemura J; Asai J; Nakazato M; Kangawa K; Matsuo H; Matsukura S
    Diabetes; 1990 May; 39(5):639-42. PubMed ID: 1970540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased plasma levels of islet amyloid polypeptide in patients with primary hyperparathyroidism.
    Valdermarsson S; Leckström A; Westermark P; Bergenfelz A
    Eur J Endocrinol; 1996 Mar; 134(3):320-5. PubMed ID: 8616529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of aging on plasma islet amyloid polypeptide basal level and response to oral glucose load.
    Mitsukawa T; Takemura J; Nakazato M; Asai J; Kanagawa K; Matsuo H; Matsukura S
    Diabetes Res Clin Pract; 1992 Feb; 15(2):131-4. PubMed ID: 1563328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.